(CTN News) – Pluvicto, Novartis’ radiotherapy, has high hopes. Despite the Swiss pharma’s efforts to move the drug into an earlier Prostate Cancer treatment setting, it has posted mixed trial results that cast a cloud of uncertainty over its regulatory road ahead. Pluvicto reduced the risk of disease worsening or death by 57% compared with […]
This post first appeared on Data Analytics Can Be A Powerful Tool Against Cybercrime’s Meteoric Rise In South East Asia, please read the originial post: here
